Breast Cancer News and Research

Latest Breast Cancer News and Research

ZIOPHARM receives Notice of Allowance for palifosfamide from U.S. patent office

ZIOPHARM Oncology, Inc. announced today that it has received a Notice of Allowance from the U.S. Patent and Trademark Office for Application Serial No. 11/257,766 entitled “Salts of Isophosphoramide mustard and analogs thereof as anti-tumor agents” with claims directed to compounds, pharmaceutical compositions, and lyophilisates. These claims cover the Company’s proprietary palifosfamide composition (ZIO-201 or ZymafosTM). The Company has recently reported positive randomized Phase II sarcoma interim data for intravenous palifosfamide at the Annual Meeting of the Connective Tissue Oncology Society (CTOS) on November 6, 2009 and expects, following U.S. Food and Drug Administration (FDA) review, to initiate a registration trial the first half of 2010.

27 Jan 2010

Findings may yield novel therapeutic strategies for late-stage breast cancer

Researchers from the Boston University School of Medicine (BUSM) have determined how the TGFβ-Smad signaling pathway, which is over activated in late-stage cancers, is responsible for the "epigenetic memory" that maintains unique patterns of regulatory DNA hypermethylation causing silencing of critical genes that facilitate breast cancer progression.

25 Jan 2010

Long-term graft retention is improved through supplementation of fat grafts with ADRCs

Results from Cytori Therapeutics’ preclinical fat grafting study have been published in the February issue of the Annals of Plastic Surgery. This article, entitled “Supplementation of Fat Grafts with Adipose-Derived Regenerative Cells (ADRCs) Improves Long-Term Graft Retention,” examines the science behind cell-enriched autologous fat grafting and its application to cosmetic and reconstructive surgery. The results demonstrate a doubling in graft retention in cell-enriched grafts and provide insight into the mechanisms behind this improvement.

25 Jan 2010

Researchers identify new gene signature that predicts cancer recurrence in certain breast tumors

Researchers at Dana-Farber Cancer Institute have discovered a gene activity signature that predicts a high risk of cancer recurrence in certain breast tumors that have been treated with commonly used chemotherapy drugs.

24 Jan 2010

The American Journal of Pathology: Highlights from February 2010 issue

A group led by Dr. Peter Lloyd Jones at the University of Dundee, Dundee, Scotland; the University of Colorado Denver, Aurora, CO; and the University of Pennsylvania, Philadelphia, PA has demonstrated that tenascin-C affects proto-oncogene function in breast cancer. Their report can be found in the February 2010 issue of The American Journal of Pathology.

22 Jan 2010

AKD Global announces new class of cancer treatments in development

AKD Global announced today the discovery of a new class of cancer treatments in development, providing hope for millions of sufferers. The spectacular results demonstrate a highly potent effect on cancer cells with no toxicity to healthy tissue. AKD is raising funds to continue development.

22 Jan 2010

New sensor could help diagnose and treat a variety of diseases

A tiny new sensor could provide fresh, inexpensive diagnosis and treatment methods for people suffering from a variety of diseases.

22 Jan 2010

Quitting smoking doubles survival chances in lung cancer patients

People diagnosed with early stage lung cancer can double their chances of survival over five years if they stop smoking compared with those who continue to smoke, finds a study published on bmj.com today.

22 Jan 2010

Teva Pharmaceutical Industries receives FDA tentative approval for generic Femara Tablets

Teva Pharmaceutical Industries Ltd. announced today that the U.S. Food and Drug Administration (FDA) has granted tentative approval for the Company's Abbreviated New Drug Application (ANDA) to market its generic version of Novartis’ breast cancer treatment Femara® (letrozole) Tablets, 2.5 mg. Final approval of Teva’s Letrozole Tablets is expected upon expiry of patent protection for the brand product in June 2011.

21 Jan 2010

Data demonstrates overall radiation with digital mammography is less than film mammography

Data from one of the largest mammography trials in history demonstrates that overall the radiation dose associated with digital mammography is significantly lower (averaging 22 percent lower) than that of conventional film mammography and that the reduction could be greater in women with larger and denser breasts, according to a study published in the February issue of the American Journal of Roentgenology.

21 Jan 2010

Genomic Health announces global commercial availability of its Oncotype DX colon cancer test

Genomic Health, Inc. today announced worldwide commercial availability of its Oncotype DX® colon cancer test, the first multigene expression test developed for the assessment of risk of recurrence in patients with stage II disease. The 12-gene advanced diagnostic test is clinically validated to predict individual recurrence risk in stage II colon cancer patients following surgery, as reported at the 2009 American Society of Clinical Oncology (ASCO) meeting.

21 Jan 2010

Stem Cell Assurance performs first regenerative cell breast augmentation surgery

Stem Cell Assurance, Inc. announced today that Arthur Handal, MD., F.A.C.S. has performed the first regenerative cell breast augmentation through its nationwide physician network. The procedure was performed at Handal Plastic Surgery in Boca Raton, Florida in the practice's onsite accredited ambulatory surgical facility.

21 Jan 2010

Medco Health Solutions launches Medco TRC for oncology patients

Medco Health Solutions, Inc. today announced the launch of the Medco Therapeutic Resource Center® (TRC) for oncology patients headquartered in Whitestown, Ind., where specialist pharmacists will manage the company's more than 850,000 patients currently living with cancer, one of the fastest growing segments of healthcare.

21 Jan 2010

First Coast Oncology uses PEM scanner and AccuBoost image guided procedure for breast cancer treatment

First Coast Oncology in Jacksonville, Florida has significantly enhanced its ability to treat breast cancer with the addition of a Naviscan PEM (Positron Emission Mammography) scanner.

20 Jan 2010

New heating therapy reduces mastectomies, kills large tumors

A new treatment developed and tested by University of Oklahoma researchers not only killed large breast cancer tumors, but reduced the need for mastectomies by almost 90 percent. The latest results appear in an upcoming issue of the Annals of Surgical Oncology.

20 Jan 2010

Radiology Regional Center initiates participation in SOMO•INSIGHT Clinical Study

U-Systems announced today that Radiology Regional Center has initiated participation in the SOMO•INSIGHT Clinical Study. The first breast center in Southwest Florida to participate, Radiology Regional Center is recruiting participants for the national clinical research study designed to evaluate whether digital mammography in combination with the somo•v™ Automated Breast Ultrasound System (ABUS) from U-Systems is more sensitive to detecting breast lesions when compared to Mammography alone in women with dense breasts.

20 Jan 2010

Ericson Manufacturing supports breast cancer research and community outreach projects

In 2010 Ericson Manufacturing Company will make significant strides in the support of national breast cancer awareness through a new partnership with Susan G. Komen for the Cure®, the world’s largest breast cancer advocacy organization.

20 Jan 2010

Sagent Pharmaceuticals introduces pamidronate disodium injection in single-dose vials

Sagent Pharmaceuticals, Inc., a privately held specialty pharmaceutical company, today announced that it has launched pamidronate disodium injection in single-dose vials containing 30 mg per 10 mL and 90 mg per 10 mL. Pamidronate disodium injection, the generic alternative of Novartis Pharmaceutical Company's Aredia®, is a bone resorption inhibitor. The 2008 U.S. market for pamidronate disodium approximated $17 million, according to IMS data.

20 Jan 2010

European Breast Cancer Conference in Barcelona, Spain

The 7th European Breast Cancer Conference (EBCC-7) will be held in Barcelona, Spain (Centre Convencions Internacional (CCIB - FORUM), Rambla Prim 1-17, ES-08019) from Wednesday 24 - Saturday 27 March 2010.

20 Jan 2010

Researchers propose a new model for breast cell differentiation

A study by researchers at Tufts University School of Medicine, the Sackler School of Graduate Biomedical Sciences at Tufts, and Tufts Medical Center improves our current understanding of the origins of breast cancer. The

19 Jan 2010

Breast Cancer News and Research

Latest Breast Cancer News and Research

ZIOPHARM receives Notice of Allowance for palifosfamide from U.S. patent office

Findings may yield novel therapeutic strategies for late-stage breast cancer

Long-term graft retention is improved through supplementation of fat grafts with ADRCs

Researchers identify new gene signature that predicts cancer recurrence in certain breast tumors

The American Journal of Pathology: Highlights from February 2010 issue

AKD Global announces new class of cancer treatments in development

New sensor could help diagnose and treat a variety of diseases

Quitting smoking doubles survival chances in lung cancer patients

Teva Pharmaceutical Industries receives FDA tentative approval for generic Femara Tablets

Data demonstrates overall radiation with digital mammography is less than film mammography

Genomic Health announces global commercial availability of its Oncotype DX colon cancer test

Stem Cell Assurance performs first regenerative cell breast augmentation surgery

Medco Health Solutions launches Medco TRC for oncology patients

First Coast Oncology uses PEM scanner and AccuBoost image guided procedure for breast cancer treatment

New heating therapy reduces mastectomies, kills large tumors

Radiology Regional Center initiates participation in SOMO•INSIGHT Clinical Study

Ericson Manufacturing supports breast cancer research and community outreach projects

Sagent Pharmaceuticals introduces pamidronate disodium injection in single-dose vials

European Breast Cancer Conference in Barcelona, Spain

Researchers propose a new model for breast cell differentiation

Industry Focus eBook - Oncology (1st Edition) eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Breast Cancer News and Research

Latest Breast Cancer News and Research

Industry Focus eBook - Oncology (1st Edition) eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in